Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors [NA]
The SBU-RESET trial investigates relaxation, stress reduction, and epigenetic approaches in cancer survivors and is currently recruiting. Th…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies [Phase 1]
This clinical trial update describes a Phase 1 safety study of CC312 in adults with relapsed/refractory CD19-positive B-cell hematologic mal…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies [Phase 1, Phase 2]
GT719 Injection is being studied in a Phase 1/2 trial for recurrent or refractory CD19-positive adult B-cell malignancies, with recruitment …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial update evaluating the combination of obinutuzumab, venetoclax, and lenalidomide in patients with relapsed or refrac…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies [EARLY_Phase 1]
This open-label, single-arm Phase 1 study is currently recruiting to evaluate the safety and preliminary efficacy of OriV508 injections in a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]
This document outlines a Phase 1/2 clinical trial evaluating a combination of homoharringtonine, a BCL-2 inhibitor, rituximab, and prednison…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Cord Blood Transplant in Adults With Blood Cancers [Phase 2]
Phase 2 trial evaluating cord blood transplant in adults with blood cancers is currently recruiting. Conditions include acute myeloid leukem…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. [Phase 1]
A Phase 1 clinical trial led by Murdoch Children's Research Institute is investigating changes in metabolism phenotype in paediatric, adoles…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. [NA]
This clinical trial update describes a post-treatment program to identify and manage complications related to oncology or hematology treatme…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
A completed Stanford-led clinical trial evaluating wearable sensors and molecular omics approaches to detect and mitigate adverse events dur…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae [NA]
Clinical trial update for a study evaluating Goal Management Training for adult survivors of childhood acute lymphoblastic leukemia and chil…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas [Phase 1]
This document reports the status of a Phase 1 clinical trial evaluating GLB-002 in patients with relapsed or refractory Non-Hodgkin Lymphoma…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies [Phase 1, Phase 2]
Clinical trial update on CLIC-1901 for relapsed/refractory CD19-positive hematologic malignancies (Phase 1/Phase 2), currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG [NA]
A clinical trial investigating early detection of anthracycline cardiotoxicity risk in lymphoma patients using TEP/CT-FDG imaging, currently…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation [Phase 2]
This clinical trial update describes a Phase 2 study evaluating TCRγδ T cells and memory T cells with selective use of blinatumomab as part …
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial of DZD8586 in relapsed or refractory B-cell non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion [Phase 2]
A Phase 2 clinical trial evaluating allogeneic stem cell transplantation with alpha/beta T cell and CD19+ B cell depletion for malignant and…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL [Phase 2]
Phase 2 clinical trial evaluating obinutuzumab plus ICE chemotherapy for refractory or recurrent CD20-positive mature non-Hodgkin lymphoma i…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) [Phase 1, Phase 2]
An update on an ongoing Phase 1/2 clinical trial evaluating Estrella Biopharma's EB103 T-cell therapy in adults with relapsed/refractory B-c…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating allogeneic CD19-targeting CAR-γδT cells for relapsed/refractory Non-Hodgkin lymphoma is currently recr…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL [Phase 1, Phase 2]
A Phase 1/2 study of an allogeneic CD19-targeting CAR-γδT cell therapy (QH103E) for relapsed/refractory non-Hodgkin lymphoma is currently re…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies [Phase 1, Phase 2]
This document outlines a Phase I/II clinical trial of ALETA-001 for various B-cell lymphomas, with recruitment ongoing and sponsored by Canc…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30) [Phase 1]
Phase 1 clinical trial of CD30-directed CAR T cells for relapsed CD30-expressing Hodgkin lymphoma and non-Hodgkin lymphoma is currently recr…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Administration of Donor T Cells With the Caspase-9 Suicide Gene [Phase 1]
A Phase 1 trial evaluating donor T cells engineered with a caspase-9 suicide gene to enable controlled safety in hematologic diseases.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT [Phase 1]
Phase 1 trial evaluating multi-virus cytotoxic T lymphocytes engineered with CD19 chimeric receptors for CD19-positive malignancies after st…